National expert consensus on gadolinium contrast use for CNS MRI

A national expert committee recommends using the lowest effective dose of macrocyclic gadolinium-based contrast agents (GBCAs) for CNS MRI, covering neuro-oncology, inflammatory, infectious, vascular, and angiographic indications; linear GBCAs have been withdrawn.

• Developed by a nationally convened expert committee; addresses neuro-oncological, inflammatory, infectious, vascular, and CNS angiographic studies.
• Recommends macrocyclic GBCAs at the lowest effective dose; marketing authorisation for certain linear GBCAs has been withdrawn.
• Emphasizes clinical and environmental safety in the use of these contrast media.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.